EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Location: Lotte New York Palace HotelLYON, France, August 29, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to participate in a fireside chat and host 1x1 investor meetings at the H.C. Wainwright 26th Annual Global Investment Conference, which is being held September 9-11, 2024, in New York City.
2024年8月29日，法國里昂 - 全球領先的機器人能源療法公司EDAP TMS SA（納斯達克股票代碼：EDAP）宣佈，首席執行官Ryan Rhodes將參加H.C. Wainwright第26屆年度全球投資大會的爐邊談話並主持1對1投資者會議。該大會將於2024年9月9日至11日在紐約市舉行。
Date: Tuesday, September 10th
日期： 9月10日星期二
Time: 3:00-3:30 PM ET
時間： 下午3:00-3:30 ET
Location: Lotte New York Palace Hotel
地點： Lotte New York Palace Hotel
Webcast:
網絡視頻會議：
The live and archived webcast of the presentation can be accessed in the Investors section of the Company's website here.
演示的現場直播和存檔的網絡直播可以在公司網站的投資者頁面這裏訪問。.
About EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit , us.hifu-prostate.com and .
關於EDAP TMS SA
EDAP TMS是全球治療性超聲市場中的知名領導者，開發，製造，推廣並在全球範圍內分銷使用超聲技術的各種病理的微創醫療設備。通過將最新的成像和治療模式技術結合在其完整的機器人HIFU設備系列中，EDAP TMS推出了Focal One，並將其作爲理想的前列腺組織消融技術在歐洲和美國應用。通過增加ExactVu微型超聲設備，EDAP TMS現在是唯一一家提供從診斷到前列腺癌局部治療的完整解決方案的公司。EDAP TMS還生產和分銷其他醫療設備，包括Sonolith i-move碎石機以及使用體外震波碎石療法（ESWL）處理尿路結石的激光器。有關本公司的更多信息，請訪問「http://www.edap-tms.com」、「us.hifu-prostate.com」、「www.focalone.com」。
作爲全球療法性超聲市場的知名領導者，EDAP TMS開發、製造、推廣和分銷使用超聲技術治療各種病理學的全球性微創醫療設備。在其完整的機器人HIFU設備的成像和治療模式的最新技術的結合下，EDAP TMS在歐洲和美國推出了Focal One，作爲理想的前列腺組織消融的解決方案。隨着 ExactVu 微型超聲設備的加入，EDAP TMS現在是唯一一家提供從診斷到前列腺癌局部治療的完整解決方案的公司。EDAP TMS還生產和分銷其他醫療設備，包括 Sonolith i-move tipter 和激光設備，用於使用ESWL治療泌尿道結石。有關該公司的更多信息，請訪問，us.hifu-prostate.com and 。
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
公司聯繫
Marcia Novero
Innodata Inc.
Mnovero@innodata.com
(201) 371-8015
Blandine Confort
投資者關係/法務部門
edap tms SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
投資者聯繫方式
John Fraunces
LifeSci Advisors，LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
譯文內容由第三人軟體翻譯。
